Replies to post #591410 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

My point is that Melero's version of dendritic cell vaccine combined with Poly-ICLC can trigger immune response on various types of solid tumors. But not good enough. Otherwise, BMY would have many collaborations with Melero on dendritic cell vaccine. Their mediocre or inferior results are going to make NWBO's DCVax-L (DCVax 2.0) look even more outstanding.